Robert Pirker
European Association of Nuclear Medicine(AT)Central European Cooperative Oncology Group(AT)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment, Lung Cancer Research Studies, Colorectal Cancer Treatments and Studies, Drug Transport and Resistance Mechanisms
Most-Cited Works
- → DNA Repair by ERCC1 in Non–Small-Cell Lung Cancer and Cisplatin-Based Adjuvant Chemotherapy(2006)1,723 cited
- → Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial(2009)1,354 cited
- → Expression of Multidrug Resistance Gene in Human Cancers(1989)1,297 cited
- → Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC(2018)652 cited
- → Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non–Small Cell Lung Cancer(2018)605 cited
- → EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study(2011)572 cited